Grants for State governments - Health

This grant provides funding for research projects focused on improving health outcomes through lifestyle medicine for individuals affected by the 9/11 attacks, including responders and survivors receiving care under the WTC Health Program.

The "Blueprint Medtech: Small Business Translator" grant aims to support small businesses in developing and testing therapeutic and diagnostic devices for nervous or neuromuscular disorders, with funding and expert assistance provided for activities such as clinical studies, safety testing, and design validation, ultimately leading to FDA or IRB approval.

The REDI: NIA Entrepreneurship Enhancement Award (R25) is a grant aimed at providing entrepreneurial training to graduate students, postdocs, and early career scientists in fields related to aging and Alzheimer's disease research, to prepare them for diverse career paths.

The Georgia Health Initiative invites organizations to apply for its 2024 Building the Field of Health Advocacy grant program, which aims to improve the health of people in Georgia through advocacy projects. This grant aligns directly with the Georgia Health Initiative's mission, vision, and values by supporting non-profit partners who are advancing advocacy initiatives to bring about change at a systems level. The overarching goal is to transform processes, power structures, policies, and/or relationships that determine how resources and services are distributed, ultimately advancing health equity across the state. The target beneficiaries are Georgians, with a focus on communities and populations that stand to benefit from improved health equity. The grant program seeks to support projects that elevate community voices to educate decision-makers on important health-related issues. The impact goals are centered around creating systemic change, ensuring a more equitable distribution of health resources and services throughout Georgia. Eligible organizations must be tax-exempt public charities, state or local government agencies, or coalitions/collaboratives using a fiscal sponsor, and must work in Georgia on behalf of Georgians. The priorities and focuses of this grant program are multifaceted. It aims to identify emerging opportunities to advance health equity in Georgia at the systems level, whether locally or statewide. Another key focus is to bolster the capacity of non-profit organizations to engage in effective advocacy efforts, which includes research, policy development, coalition building and mobilization, community education, and strategic communications. Furthermore, the initiative seeks to strengthen the overall field of health advocacy in Georgia. Expected outcomes and measurable results include the successful implementation of advocacy initiatives that lead to tangible changes in systems, policies, and power structures affecting health. This could manifest as new policies enacted, improved access to services, or stronger community engagement in health decision-making processes. The grant aims to foster a more robust and effective health advocacy ecosystem in Georgia, with a greater number of capable non-profit organizations driving positive change. The Initiative anticipates investing a total of $1.2 million, with organizations able to apply for up to $75,000 for projects lasting up to 12 months, allowing for sustained and impactful advocacy work.

This funding opportunity supports promising predoctoral students from diverse backgrounds to conduct research in translational studies related to Alzheimer's disease and related dementias, fostering skills essential for advancing this critical field.

Notice of Funding Opportunity Description Background Although vaccines are among the most effective approaches to control viral diseases, developing a prophylactic or therapeutic HIV vaccine has proven elusive. There are no licensed vaccines for HIV. Strategies for induction of HIV broadly neutralizing antibodies will likely require repeated exposures over long periods, including immunization with distinct antigens in sequential order. Such immunization strategies will require development of technologies for controlled vaccine release. Recent advances in materials-based science, controlled release technologies, delivery systems, and immunology provide opportunities to enhance the quality, potency and durability of vaccine-induced T cell and antibody responses to HIV-1. Materials-based approaches can be engineered to improve the stability, spatiotemporal release, and presentation of multiple vaccine components; for example, by controlling the time frame and dose of vaccine delivery over days to weeks. Recent studies have shown that a slow-release vaccine is superior to bolus administration at inducing breadth, potency, and durability of antibody responses to HIV antigens by prolonging antigen exposure in the germinal centers, thereby enhancing the maturation of B cells and generating stronger humoral immune responses. Further research is needed to elucidate the mechanisms underlying the immunological improvements observed with slow-release vaccine delivery and to translate such concepts into clinical application. It will be crucial to determine how the duration of exposure to vaccine components impacts immune cell biology, and how to calibrate vaccine release to improve responses while avoiding immune exhaustion and over-activation. Advancing safe, effective, and well-tolerated controlled release vaccines is an unmet need that may enhance vaccine effectiveness and practicality, leading to better adherence to complex regimens, fewer adverse reactions, and cost savings. Finally, iterative behavioral studies during product development to determine vaccine/provider product expectation/preferences are critical to facilitate product uptake and use.

This funding opportunity supports postdoctoral researchers conducting studies on the impact of early environmental factors on child health using a large national dataset.

This funding opportunity supports primary care centers in implementing genomic screening for common genetic conditions to improve disease prevention and care, particularly in underrepresented communities.

CareQuest Institute for Oral Health will fund school based and school linked initiatives to improve oral health and access for children and their families. As part of its philanthropic strategy to strengthen communities and improve oral health systems, the program aims to address barriers for high risk children to prevent dental disease and support health and academic success. The opportunity will fund up to ten projects at up to 125,000 dollars each. Eligible entities are public entities and nonprofit organizations that are tax exempt under Section 501(c)(3) and are based and operating in the United States or its territories. Funds may be used to design and implement programs that bring preventive and restorative services, education, and linkages to care in school based or school linked settings. Applicants should present clear goals, activities, and evaluation plans that demonstrate expected outcomes and community benefit consistent with CareQuest Institute priorities. The grant period length is not specified beyond the individual award cap. Applications are due May 1, 2024 through CareQuest Institute’s described submission process. Additional information is available from CareQuest Institute for Oral Health.

This funding opportunity supports research initiatives focused on non-communicable diseases related to HIV at institutions in low- and middle-income countries, encouraging innovative projects and collaborations to improve health outcomes for people living with HIV.

This funding opportunity provides financial support to education and health agencies for developing and implementing sustainable school-based strategies to prevent HIV and STDs among middle and high school students in the United States.

This Notice of Funding Opportunity (NOFO) seeks to foster new multi-disciplinary teams to address how HIV Comorbidities and co-infections within the missions of NIDDK and NIAID interact with viral reservoirs, potentially confounding cure strategies aimed at either sustained viral suppression or elimination from the body. These teams will mechanistically interrogate the impact of inflammation, metabolic perturbations, or other pathophysiological processes associated with these comorbidities or co-infections on reservoir dynamics, and/or the interplay of these conditions and co-infections on HIV reservoir biology in ways that are likely to interact with potential cure strategies.

This funding opportunity provides rapid financial support for researchers to study health outcomes related to urgent events like pandemics, natural disasters, or sudden policy changes, allowing them to gather critical data quickly.

This funding opportunity provides financial support to Ohio's local mental health and addiction boards and qualified non-profit organizations to expand prevention, treatment, and recovery services for individuals affected by opioid and stimulant use disorders.

This grant provides funding for early stage investigators to pursue innovative and high-risk research projects involving human participants, without the need for preliminary data.

This funding opportunity supports innovative research aimed at understanding and improving treatment for schizophrenia and related disorders in individuals aged 35 and older.

This funding opportunity provides resources to rural health networks to improve access, coordination, and quality of essential health services for underserved populations in rural communities.

This funding opportunity provides financial support to state, local, and Tribal governments, as well as non-profit organizations, to improve energy efficiency in low-income homes and develop a skilled workforce in the clean energy sector.

The purpose of this funding opportunity announcement is to provide tailored support for early stage investigators (ESIs) to initiate basic or translational research with nonhuman primates (NHPs). These awards will allow ESIs additional funds, time to generate preliminary data, and the opportunity to establish all skills needed to set up and run an NHP laboratory independently. It is expected that these awards will thereby improve an ESIs ability to secure larger research awards (e.g., R01) and will facilitate their transition to independent tenure-track positions.

This funding opportunity supports researchers conducting small clinical trials to develop and test innovative devices for recording and stimulating the human brain, aimed at treating central nervous system disorders.